BRYCE STALLINGS: Open Payments
NPI 1326314188 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,752 in 262 payments from 21 companies in 2025. Trend: 2023 $2,857 · 2024 $5,198 · 2025 $5,752
Food & beverage: $5,477Education: $274
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $798 |
| ABBVIE INC. | 40 | $725 |
| Regeneron Healthcare Solutions, Inc. | 26 | $634 |
| Janssen Biotech, Inc. | 16 | $477 |
| Incyte Corporation | 15 | $417 |
| Organon LLC | 10 | $340 |
| Arcutis Biotherapeutics, Inc. | 23 | $331 |
| Novartis Pharmaceuticals Corporation | 15 | $317 |
| Galderma Laboratories, L.P. | 28 | $302 |
| GENZYME CORPORATION | 13 | $265 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, Zoryve, VTAMA, OPZELURA, NEMLUVIO.
Industry payments across SC — which companies pay providers there.
